Published in Eur J Cancer on October 01, 2001
Improve the Treatment of Thoracic Esophageal Cancer | NCT01137123
Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study | NCT00100321
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02
Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A (2004) 10.99
ESUR prostate MR guidelines 2012. Eur Radiol (2012) 8.86
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ (2010) 7.15
Retracted XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A (2009) 6.72
NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res (2010) 4.10
Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell (2010) 3.72
How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst (2014) 3.43
Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol (2006) 3.13
Environmental causes of esophageal cancer. Gastroenterol Clin North Am (2009) 2.80
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol (2005) 2.72
Pancreatic carcinogenesis. Pancreatology (2008) 2.60
Biology and management of pancreatic cancer. Gut (2007) 2.53
Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) (2008) 2.46
Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell (2010) 2.43
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer (2005) 2.32
Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut (2005) 2.31
Atomic model of the papillomavirus capsid. EMBO J (2002) 2.27
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging (2011) 1.99
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer. Proc Natl Acad Sci U S A (2012) 1.90
Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer (2003) 1.87
Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res (2009) 1.84
Hepatitis B virus-induced oncogenesis. World J Gastroenterol (2007) 1.82
Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev (2009) 1.78
Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol (2007) 1.73
Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol (2008) 1.60
Health state utilities for non small cell lung cancer. Health Qual Life Outcomes (2008) 1.56
Modelling prognostic factors in advanced pancreatic cancer. Br J Cancer (2008) 1.53
Environmental pollutants and breast cancer. Environ Health Perspect (2003) 1.53
Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer (2006) 1.51
Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer (2007) 1.48
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer (2006) 1.48
The endocannabinoid system and cancer: therapeutic implication. Br J Pharmacol (2011) 1.46
Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut (2005) 1.46
Retracted Association of CYP2A6*4 with susceptibility of lung cancer: a meta-analysis. PLoS One (2013) 1.45
Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study. PLoS One (2014) 1.43
Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol Biomarkers Prev (2009) 1.43
Interactions between papillomavirus L1 and L2 capsid proteins. J Virol (2003) 1.41
Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology (2011) 1.41
Feasibility and accuracy of second-look laparoscopy after gastrectomy for gastric cancer. Surg Endosc (2009) 1.39
Cancer burden and trends in the Asian Pacific Rim region. Asian Pac J Cancer Prev (2004) 1.39
Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinformatics (2006) 1.39
Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiol Biomarkers Prev (2011) 1.36
Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut (2005) 1.32
Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev (2009) 1.30
Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Virol J (2010) 1.29
Family history and the risk of gastric cancer. Br J Cancer (2009) 1.27
Patient priorities in colorectal cancer screening decisions. Health Expect (2005) 1.24
Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. J Biol Chem (2008) 1.23
Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood (2007) 1.22
Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin Cancer Res (2008) 1.22
Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell. Biophys J (2006) 1.22
Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency. BMC Int Health Hum Rights (2010) 1.20
Psychosocial working conditions and the risk of esophageal and gastric cardia cancers. Eur J Epidemiol (2004) 1.18
Cancer rehabilitation: psychosocial rehabilitation needs after discharge from hospital? Scand J Prim Health Care (2008) 1.17
Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi J Gastroenterol (2008) 1.17
Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev (2007) 1.16
Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer. Onco Targets Ther (2014) 1.16
Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut (2006) 1.15
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg (2008) 1.15
Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. Future Oncol (2010) 1.14
Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma. Br J Cancer (2010) 1.13
Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer? World J Gastroenterol (2012) 1.12
Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environ Health (2011) 1.12
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. J Viral Hepat (2009) 1.10
Net1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer (2006) 1.09
Efficacy and complication of endoscopic submucosal dissection for superficial esophageal carcinoma: a systematic review and meta-analysis. J Cardiothorac Surg (2014) 1.08
CXCL5 overexpression is associated with late stage gastric cancer. J Cancer Res Clin Oncol (2007) 1.08
Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels. Croat Med J (2009) 1.08
Prostate cancer incidence and mortality in barbados, west indies. Prostate Cancer (2011) 1.07
Radiation-stimulated epigenetic reprogramming of adaptive-response genes in the lung: an evolutionary gift for mounting adaptive protection against lung cancer. Dose Response (2009) 1.07
Hepatocellular carcinoma in the world and the middle East. Middle East J Dig Dis (2010) 1.07
Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia. Gastroenterology (2013) 1.07
Is gastric cancer preventable? Gut (2004) 1.06
Evaluation of prostate cancer characteristics in four populations worldwide. Can J Urol (2008) 1.06
Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol (2007) 1.04
Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer (2009) 1.04
Regulation of human papillomavirus gene expression by splicing and polyadenylation. Nat Rev Microbiol (2013) 1.04
Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas. Mayo Clin Proc (2009) 1.04
Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions. Gastroenterology (2015) 1.04
Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma. BMC Gastroenterol (2012) 1.03
The impact of obesity on LADG for early gastric cancer. Gastric Cancer (2006) 1.03
Is there a role for consolidative radiotherapy in the treatment of aggressive and localized non-Hodgkin lymphoma? A systematic review with meta-analysis. BMC Cancer (2012) 1.03
Informing men about prostate cancer screening: a randomized controlled trial of patient education materials. J Gen Intern Med (2008) 1.03
Community-initiated breast cancer and environment studies and the precautionary principle. Environ Health Perspect (2005) 1.03
A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev (2014) 1.02
Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency. BMC Med Genomics (2009) 1.02
A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth. BMC Cancer (2009) 1.02
Metabolism addiction in pancreatic cancer. Cell Death Dis (2014) 1.02
Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol (2012) 1.02
Cancer surviving patients' rehabilitation - understanding failure through application of theoretical perspectives from Habermas. BMC Health Serv Res (2008) 1.01
Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage. Gastroenterology (2014) 1.00
Early gastric cancer: concepts, diagnosis, and management. Int J Clin Oncol (2005) 1.00
Continuing controversy over monitoring men with localized prostate cancer: a systematic review of programs in the prostate specific antigen era. J Urol (2006) 1.00
Anticipation in familial pancreatic cancer. Gut (2005) 1.00
FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor. Oncotarget (2014) 1.00
Percutaneous local ablation of unifocal subclinical breast cancer: clinical experience and preliminary results of cryotherapy. Eur Radiol (2011) 0.99
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Lung cancer. Cancer (1995) 4.50
International trends and patterns of prostate cancer incidence and mortality. Int J Cancer (2000) 3.73
Cancer incidence and mortality trends in the United States: 1935-74. J Natl Cancer Inst (1978) 3.01
Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst (2001) 2.73
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Socioeconomic and racial differences in lung cancer incidence. Am J Epidemiol (1983) 2.54
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst (1999) 2.38
Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ (2012) 2.38
Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36
Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst (2000) 2.35
Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer (2009) 2.33
Association of breast cancer and cervical cancer incidence with income and education among whites and blacks. J Natl Cancer Inst (1980) 2.21
Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev (2001) 2.14
Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer (1999) 1.84
Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer (1999) 1.83
Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer (1997) 1.82
Patterns of occurrence of the leukaemias. Eur J Cancer (1995) 1.77
Demographic characteristics of cancer of the pancreas: mortality, incidence, and survival. Cancer (1981) 1.58
Cervical cancer. Cancer Surv (1994) 1.57
The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites. Int J Cancer (1997) 1.57
Hodgkin's and non-Hodgkin's lymphomas. Cancer Surv (1994) 1.55
Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res (1992) 1.54
Testicular cancer in the United States: trends in incidence and mortality. Int J Epidemiol (1986) 1.52
Epidemiology of bladder cancer. Hematol Oncol Clin North Am (1992) 1.50
Rising incidence of biliary tract cancers in Shanghai, China. Int J Cancer (1998) 1.45
Laterality of breast cancer in the United States. Cancer Causes Control (1996) 1.44
Alternate ranging methods for cancer mortality maps. J Natl Cancer Inst (2000) 1.41
Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol Biomarkers Prev (1998) 1.33
Descriptive epidemiology of cancer of the uterine cervix. Obstet Gynecol (1984) 1.32
Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst (1996) 1.31
Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst (2000) 1.29
Declining breast cancer mortality among young American women. J Natl Cancer Inst (1987) 1.29
The rising incidence of gastric cardia cancer. J Natl Cancer Inst (1999) 1.29
Third National Cancer Survey--an overview of available information. J Natl Cancer Inst (1974) 1.29
Assessing the validity of observed cancer incidence trends. Am J Epidemiol (1984) 1.28
Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994. Cancer (1998) 1.27
In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol (1992) 1.23
Death certificate reporting of colon and rectal cancers. JAMA (1992) 1.18
The incidence of retinoblastoma. Am J Ophthalmol (1975) 1.16
Socioeconomic status and breast cancer mortality, 1989 through 1993: an analysis of education data from death certificates. Am J Public Health (1997) 1.16
Descriptive epidemiology of childhood leukaemia. Br J Cancer (1991) 1.12
Childhood cancer: overview of incidence trends and environmental carcinogens. Environ Health Perspect (1995) 1.12
The prevalence of cancer among adults in the United States: 1987. Cancer (1992) 1.11
Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use. Epidemiology (2000) 1.10
Risk of cancer in migrants and their descendants in Israel: II. Carcinomas and germ-cell tumours. Int J Cancer (1997) 1.09
International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007. Andrology (2014) 1.07
Cancer incidence trends in urban Shanghai, 1972-1989. Int J Cancer (1993) 1.05
Declining incidence is greater for esophageal than gastric cancer in Shanghai, People's Republic of China. Br J Cancer (1993) 0.98
Using a mixed effects model to estimate geographic variation in cancer rates. Biometrics (1999) 0.95
Trends in the incidence of endometrioid and clear cell cancers of the ovary in the United States. Am J Epidemiol (1981) 0.93
Underreporting and misclassification of urinary tract cancer cases on death certificates. Epidemiology (1996) 0.92
Epidemiologic patterns of colorectal cancer. Important Adv Oncol (1986) 0.91
Incidence trends for cancers of the breast, ovary, and corpus uteri in urban Shanghai, 1972-89. Cancer Causes Control (1993) 0.89
Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur J Cancer Prev (2004) 0.89
Incidence of cancer in United States blacks. Cancer Res (1975) 0.88
Racial differences in the risk of invasive squamous-cell cervical cancer. Cancer Causes Control (1991) 0.88
Seasonal variation in frequency of diagnosis of cutaneous malignant melanoma. Melanoma Res (1994) 0.88
Proceedings: Epidemiology of gastrointestinal cancer. Proc Natl Cancer Conf (1972) 0.87
Increasing incidence of non-Hodgkin's lymphoma. Semin Hematol (1993) 0.86
An ecological study of cancer incidence and radon levels in South West England. Eur J Cancer (1996) 0.86
Rising incidence of prostate cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev (1998) 0.84
Colon cancer incidence: recent trends in the United States. Cancer Causes Control (1991) 0.83
Cancer registration in Connecticut and the study of multiple primary cancers, 1935-82. Natl Cancer Inst Monogr (1985) 0.82
Oral and pharyngeal cancers. Cancer Surv (1994) 0.82
Retinoblastoma incidence and sunlight exposure. Br J Cancer (2000) 0.81
Recent trends in the incidence of testicular germ cell tumors in the United States. Andrology (2014) 0.81
Cancer mortality, incidence, and patient survival among American women. Women Health (1987) 0.80
Epidemiology of human leukemia. Curr Opin Hematol (1994) 0.78
The magnitude of the breast cancer problem. Recent Results Cancer Res (1976) 0.77
Increase in the number of cancer deaths in the United States. Am J Epidemiol (1977) 0.75
Trends in the incidence of cancer in Atlanta -- 1937-1978. J Med Assoc Ga (1981) 0.75
Contamination of poliovirus vaccine with SV40 and the incidence of medulloblastoma. Med Pediatr Oncol (1999) 0.75
Prostate cancer mortality in the United States by cohort year of birth, 1865-1940. Cancer Epidemiol Biomarkers Prev (1995) 0.75
Letter: Polycythemia vera among the elderly. JAMA (1975) 0.75
Rising incidence of colon cancer in Shanghai. Cancer Epidemiol Biomarkers Prev (1993) 0.75
Reliability of reported death rates and incidence rates. Prev Med (1980) 0.75
Trends in incidence and mortality in the United States. J Environ Pathol Toxicol (1980) 0.75
Protective effect of oestrogen in pancreatic cancer. Lancet (1988) 0.75
The third national cancer survey. Proc Natl Cancer Conf (1970) 0.75